Pharmacy chain CVS Well being stated it’s pulling a few of its hottest chilly and cough drugs from retailer cabinets, weeks after advisers to the Meals and Drug Administration deemed a typical ingredient ineffective.

CVS instructed CBS MoneyWatch that it’s going to now not promote merchandise that solely comprise phenylephrine as an energetic ingredient at its pharmacy shops. 

“We’re eradicating sure oral cough and chilly merchandise that comprise phenylephrine as the one energetic ingredient from CVS Pharmacy shops,” the corporate stated in an announcement to CBS MoneyWatch.

“Different oral cough and chilly merchandise will proceed to be supplied to fulfill shopper wants,” CVS added.

CVS stated it’s conscious of the FDA Advisory Committee’s place on oral phenylephrine and is dedicated to complying with all relevant legal guidelines and laws. It’s pulling the decongestants voluntarily.

Oral phenylephrine is present in Dayquil, Mucinex Sinus-Max, Sudafed PE Sinus Congestion, Theraflu and different well-liked drugs offered at pharmacies throughout the U.S.

“Trendy research, when effectively performed, will not be displaying any enchancment in congestion with phenylephrine,” Dr. Mark Dykewicz, an allergy specialist on the Saint Louis College Faculty of Medication, stated final month. 

Decongestants with phenylephrine account for roughly $1.8 billion in annual gross sales, in keeping with the FDA.

It is unclear if different pharmacies will observe swimsuit and take away medicine by which phenylephrine is the one energetic ingredient. Walgreens didn’t say if it should cease promoting the drugs, telling CBS MoneyWatch that it “follows FDA laws.”

“We’re intently monitoring the scenario and actively partnering with the Walgreens Workplace of Medical Integrity and suppliers on applicable subsequent steps,” a spokesperson instructed CBS MoneyWatch. 

Ceremony Support didn’t instantly reply to a request for remark. 

—The Related Press contributed to this report.